DrugPatentWatch Database Preview
RENOVA Drug Profile
» See Plans and Pricing
Which patents cover Renova, and when can generic versions of Renova launch?
Renova is a drug marketed by Valeant Pharms North and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in RENOVA is tretinoin. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
US ANDA Litigation and Generic Entry Outlook for Renova
A generic version of RENOVA was approved as tretinoin by PERRIGO PHARMA INTL on December 24th, 1998.
Summary for RENOVA
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 117 |
| Patent Applications: | 7,250 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for RENOVA |
| DailyMed Link: | RENOVA at DailyMed |
Pharmacology for RENOVA
| Drug Class | Retinoid |
US Patents and Regulatory Information for RENOVA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | AB2 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RENOVA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | Start Trial | Start Trial |
| Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | Start Trial | Start Trial |
| Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RENOVA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 8800466 | Start Trial |
| Japan | S59164710 | Start Trial |
| United Kingdom | 8306254 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for RENOVA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | 132013902214376 | Italy | Start Trial | PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718 |
| 1304992 | 92401 | Luxembourg | Start Trial | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
| 1304992 | 1390049-3 | Sweden | Start Trial | PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
